TSX:NVCN - Toronto Stock Exchange - CA64065J4037 - Common Stock - Currency: CAD
TSX:NVCN (4/10/2023, 7:00:00 PM)
40.15
+0.23 (+0.58%)
The current stock price of NVCN.CA is 40.15 CAD. In the past month the price decreased by -1.21%. In the past year, price increased by 203.02%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
PRN.CA | PROFOUND MEDICAL CORP | N/A | 229.28M | ||
MIR.CA | MEDMIRA INC | N/A | 60.66M | ||
TLT.CA | THERALASE TECHNOLOGIES INC | N/A | 47.08M | ||
NSCI.CA | NANALYSIS SCIENTIFIC CORP | N/A | 28.30M | ||
ASG.CA | AURORA SPINE CORP | N/A | 25.48M | ||
MDX.CA | MEDX HEALTH CORP | N/A | 22.86M | ||
PINK.CA | PERIMETER MEDICAL IMAGING AI | N/A | 21.97M | ||
VPT.CA | VENTRIPOINT DIAGNOSTICS LTD | N/A | 17.14M | ||
CNVI.CA | CONAVI MEDICAL CORP | N/A | 15.93M | ||
THRM.CA | THERMA BRIGHT INC | N/A | 9.09M |
Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. The company is headquartered in Richmond British Columbia, British Columbia. The company went IPO on 2001-05-23. The firm develops, manufactures, and markets products for the cardiovascular marketplace. The firm is engaged in the development of minimally invasive therapies in cardiovascular care: refractory angina and mitral valve regurgitation. Its products include the Neovasc Reducer (Reducer), for the treatment of refractory angina, and the Tiara (Tiara), for the transcatheter treatment of mitral valve disease, which is currently under clinical investigation in the United States, Canada, Israel and Europe. The firm operates through one business segment: the development, manufacturing and marketing of medical devices. The firm's subsidiaries include Neovasc Medical Inc., Neovasc Tiara Inc., Neovasc (US) Inc., Neovasc Medical Ltd., B-Balloon Ltd., Neovasc GmbH, and Neovasc Management Inc. The firm carries its business in Canada, the United States and Europe.
Neovasc Inc
Richmond, 5138-13562 Maycrest Way
Richmond British Columbia BRITISH COLUMBIA V6V 2J7 CA
CEO: Fredericus A. Colen
Employees: 71
Phone: 16042704344.0
The current stock price of NVCN.CA is 40.15 CAD. The price increased by 0.58% in the last trading session.
The exchange symbol of Neovasc Inc is NVCN and it is listed on the Toronto Stock Exchange exchange.
NVCN.CA stock is listed on the Toronto Stock Exchange exchange.
Neovasc Inc (NVCN.CA) has a market capitalization of 110.57M CAD. This makes NVCN.CA a Micro Cap stock.
Neovasc Inc (NVCN.CA) currently has 71 employees.
Neovasc Inc (NVCN.CA) has a support level at 40.12 and a resistance level at 40.84. Check the full technical report for a detailed analysis of NVCN.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NVCN.CA does not pay a dividend.
Neovasc Inc (NVCN.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-142.14).
ChartMill assigns a technical rating of 7 / 10 to NVCN.CA. When comparing the yearly performance of all stocks, NVCN.CA is one of the better performing stocks in the market, outperforming 98.96% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to NVCN.CA. NVCN.CA may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months NVCN.CA reported a non-GAAP Earnings per Share(EPS) of -142.14. The EPS decreased by -1143.35% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | 0.81 |
ChartMill assigns a Buy % Consensus number of 86% to NVCN.CA. The Buy consensus is the average rating of analysts ratings from 7 analysts.